Collegium Pharmaceutical: Some Positives From Its Quarterly ‘Miss’ (NASDAQ:COLL)
wildpixel Today, we are putting Collegium Pharmaceutical, Inc. (NASDAQ:COLL) in the spotlight. The stock of this small biopharma name fell some 16% on Friday after the company posted Q1 results that slightly missed both top and bottom-line expectations. The company also announced it was replacing its CEO. However, there were some positives from these results…